Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA016672-21S1
Application #
2086517
Study Section
Cancer Center Support Review Committee (CCS)
Project Start
1978-07-01
Project End
1997-06-30
Budget Start
1995-07-20
Budget End
1996-06-30
Support Year
21
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
Other Domestic Higher Education
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Fathi, Amir T; Erba, Harry P; Lancet, Jeffrey E et al. (2018) A phase 1 trial of vadastuximab talirine combined with hypomethylating agents in patients with CD33-positive AML. Blood 132:1125-1133
Jain, Preetesh; Kanagal-Shamanna, Rashmi; San Lucas, F Anthony et al. (2018) Clinicopathological characteristics, outcomes and pattern of mutations in patients with follicular lymphoma who progressed on Bruton tyrosine kinase inhibitors. Br J Haematol 182:718-723
Liu, Wei; Chen, Juan; Tamayo, Archito T et al. (2018) Preclinical efficacy and biological effects of the oral proteasome inhibitor ixazomib in diffuse large B-cell lymphoma. Oncotarget 9:346-360
Cinciripini, Paul M; Minnix, Jennifer A; Green, Charles E et al. (2018) An RCT with the combination of varenicline and bupropion for smoking cessation: clinical implications for front line use. Addiction :
Melamed, Alexander; Margul, Daniel J; Chen, Ling et al. (2018) Survival after Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer. N Engl J Med 379:1905-1914
Woodard, Terri Lynn; Hoffman, Aubri S; Crocker, Laura C et al. (2018) Pathways: patient-centred decision counselling for women at risk of cancer-related infertility: a protocol for a comparative effectiveness cluster randomised trial. BMJ Open 8:e019994
William Jr, William N; Tsao, Anne S; Feng, Lei et al. (2018) Single Arm, Phase II Study of Cisplatin, Docetaxel, and Erlotinib in Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinomas. Oncologist 23:526-e49
Jabbour, Elias; Sasaki, Koji; Ravandi, Farhad et al. (2018) Chemoimmunotherapy with inotuzumab ozogamicin combined with mini-hyper-CVD, with or without blinatumomab, is highly effective in patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first salvage. Cancer 124:4044-4055
Ricketts, Christopher J; De Cubas, Aguirre A; Fan, Huihui et al. (2018) The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep 23:313-326.e5
Kantarjian, Hagop M; DiNardo, Courtney D; Nogueras-Gonzalez, Graciela M et al. (2018) Results of second salvage therapy in 673 adults with acute myelogenous leukemia treated at a single institution since 2000. Cancer 124:2534-2540

Showing the most recent 10 out of 12418 publications